FDA Approvals Roundup: Kloxxado, Farxiga, Ferriprox
The Pharma Data
MAY 5, 2021
It also provided supporting pharmacokinetic data demonstrating the opioid antagonist’s safety and efficacy. . The approval was based on results in a prespecified interim analysis of the first 264 patients of the ongoing KEYNOTE-811 trial. © 2021 Regulatory Affairs Professionals Society. New indications. Source link.
Let's personalize your content